![]() |
|
|---|---|
| Data Sheet for RP1Matriptase2 | |
| Product Name | Rabbit Antibody to Matriptase-2 (MTSP-2, TMSP6, PVAE354) Cytoplasmic Domain |
| Catalog Number | RP1Matriptase2 |
| Product size | 100 ug |
| Description | RP1-Matriptase-2 is a polyclonal antibody made to the Type-II serine protease matriptase-2. The antibody is made to a synthetic peptide based on the cytoplasmic domain of human matriptase-2. RP1-Matriptase-2 reacts with human, mouse and rat matriptase-2, and does not recognize matriptase-1. The antibody has been peptide-affinity purified, concentrated to 1.0 mg/ml, with the addition of 0.05% sodium azide as preservative and 50% glycerol as cryoprotectant. |
| Use | Matriptase-2, also known as MTSP-2 (membrane-type serine proteinase-2), TMSP6 (Type-II Membrane Serine Proteinase-6) and PVAE354, is a type-II serine proteinase. The full-length human matriptase-2 is an 802 amino acid protein with predicted (unmodified) mass of 88.9 kDa, and a pI of 6.04. Secreted Matriptase-2 is glycosylated, and runs at approximately 95 kDa on reduced SDS-PAGE gels. Matriptase-2 shares approximately 37% identity with matriptase-1 and matriptase-3, mostly in the catalytic domain. Matriptase-2 is an S1A family proteinase, in the PA clan of serine proteinases, which includes trypsin, chymotrypsin, acrosin, and many other key enzymes. A literature alias exists for MTSP-2, the Mouse Serine-Type Proteinase, granzyme-A. Matriptase-2 is organized by an aminoterminal cytoplasmic domain, followed by a transmembrane domain, a stem region and then two CUB domains, three LDL receptor-like motifs, and a carboxyterminal catalytic domain. Like matriptase-1, matriptase-2 is shed from the membrane by a cleavage in the stem region, and the catalytic domain can be cleaved from the regulatory domains to generate a free trypsin-like enzyme. The liberated catalytic domain is not detected by the RP1-Matriptase-2 antibody. Matriptase-2 may be more limited in distribution than matriptase-1, and has been identified in the liver by message, but appears to be in kidney, liver and uterus, and in a number of cell lines. A recommended starting concentration for Western blots is 1:1,000 when using colorimetric substrates such as BCIP/NBT, and 1:5,000 for chemiluminescent substrates. Higher concentrations of antibody may be needed for samples from more distantly related species. EDTA/EGTA treatment of tissues or lysates is required to see latent zymogen. FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS. |
| Storage | The undiluted antibody solution is stable for approximately 12 months at -20°C. |
Ordering![]() |
Triple Point Biologics products are sold exclusively through Abcam. For availability, pricing and buying information please select your country below and press 'Go'. You will be relocated to the relevant datasheet page on Abcam's website. |